Medical cannabis products are legal in the UK from today – in very limited circumstances. This could include products without marketing authorisation, if approved by a registered specialist in certain conditions.
A change in the law brought about in a few short months enables cannabis-based products for medicinal use in humans to be prescribed as a Schedule 2 drug – essentially drugs that can be legally prescribed but carry higher risks for potential abuse.
This could be a special medicinal product for use at the direction of a doctor on the General Medical Council’s specialist register; an investigational medicinal product without marketing authorisation for use in a clinical trial; or a medicinal product with a marketing authorisation.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.
Interested in obtaining data on consumer behaviour?
Check out our new consumer survey report: CBD use in the UK market
CBD products are popular in the UK for a variety of reasons across a wide-ranging consumer base. This report offers a detailed picture of the UK CBD market, covering a range of topics such as reasons for use, length of use, consumer spending, purchase channels and user experiences and attitudes.